These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19162327

  • 1. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
    Katoh A, Matsumura Y, Yoshikawa Y, Yasui H, Sakurai H.
    J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
    [Abstract] [Full Text] [Related]

  • 2. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH, Liboiron BD, Sun Y, Bellman KD, Setyawati IA, Patrick BO, Karunaratne V, Rawji G, Wheeler J, Sutton K, Bhanot S, Cassidy C, McNeill JH, Yuen VG, Orvig C.
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [Abstract] [Full Text] [Related]

  • 4. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
    Karmaker S, Saha TK, Yoshikawa Y, Yasui H, Sakurai H.
    J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The pharmacology of the insulinomimetic effect of zinc complexes.
    Sakurai H, Adachi Y.
    Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
    Saha TK, Yoshikawa Y, Sakurai H.
    ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
    [Abstract] [Full Text] [Related]

  • 11. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y.
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
    Moniz T, Amorim MJ, Ferreira R, Nunes A, Silva A, Queirós C, Leite A, Gameiro P, Sarmento B, Remião F, Yoshikawa Y, Sakurai H, Rangel M.
    J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
    [Abstract] [Full Text] [Related]

  • 13. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
    Thompson KH, Chiles J, Yuen VG, Tse J, McNeill JH, Orvig C.
    J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
    [Abstract] [Full Text] [Related]

  • 14. Aminoacid-derivatised picolinato-oxidovanadium(IV) complexes: characterisation, speciation and ex vivo insulin-mimetic potential.
    Esbak H, Enyedy EA, Kiss T, Yoshikawa Y, Sakurai H, Garribba E, Rehder D.
    J Inorg Biochem; 2009 Apr; 103(4):590-600. PubMed ID: 19121544
    [Abstract] [Full Text] [Related]

  • 15. Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships.
    Rangel M, Amorim MJ, Nunes A, Leite A, Pereira E, de Castro B, Sousa C, Yoshikawa Y, Sakurai H.
    J Inorg Biochem; 2009 Apr; 103(4):496-502. PubMed ID: 19195710
    [Abstract] [Full Text] [Related]

  • 16. A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.
    Sakurai H.
    Chem Rec; 2002 Apr; 2(4):237-48. PubMed ID: 12203906
    [Abstract] [Full Text] [Related]

  • 17. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
    Monga V, Thompson KH, Yuen VG, Sharma V, Patrick BO, McNeill JH, Orvig C.
    Inorg Chem; 2005 Apr 18; 44(8):2678-88. PubMed ID: 15819553
    [Abstract] [Full Text] [Related]

  • 18. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
    Buglyó P, Crans DC, Nagy EM, Lindo RL, Yang L, Smee JJ, Jin W, Chi LH, Godzala Iii ME, Willsky GR.
    Inorg Chem; 2005 Jul 25; 44(15):5416-27. PubMed ID: 16022540
    [Abstract] [Full Text] [Related]

  • 19. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
    Fugono J, Yasui H, Sakurai H.
    J Pharm Pharmacol; 2005 May 25; 57(5):665-9. PubMed ID: 15901357
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
    Bolkent S, Bolkent S, Yanardag R, Tunali S.
    Diabetes Res Clin Pract; 2005 Nov 25; 70(2):103-9. PubMed ID: 16188572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.